Catalyst Event
Regeneron Pharmaceuticals Inc (REGN) · Other
From KEDI U.S. Quality500 + Monthly 1% Premium Index(NTR) (KUSQL500P)
4/23/2026, 12:00:00 AM
On April 23, 2026, the FDA granted accelerated approval for Otarmeni, the first gene therapy for genetic hearing loss. Regeneron will provide the therapy for free in the U.S. and received a valuable Priority Review Voucher.
Korean Translation
2026년 4월 23일, FDA는 유전성 난청에 대한 최초의 유전자 치료제인 오타르메니(Otarmeni)를 신속 승인함. 리제네론은 미국 내에서 해당 치료제를 무료로 제공할 예정이며, 가치 있는 우선심사바우처를 획득함.
Related Recent Events
Procter & Gamble Co (The) (PG) · Earnings Release
Analysts forecast Procter & Gamble to release its Q4 2026 earnings report on August 4, 2026, forecasted. Low impact is estimated as the announcement date itself typically has minimal immediate price effect.
8/4/2026, 12:00:00 AM
PG&E Corp (PCG) · Earnings Release
PG&E Corp is scheduled to release Q2 2026 earnings on 2026-07-30, with analysts forecasting EPS of $0.37. Low importance is estimated as routine utility earnings typically result in <5% price impact, scheduled.
7/30/2026, 12:00:00 AM
Newmont Corporation (NEM) · Other
Retirement of Francois Hardy, Executive Vice President and Chief Technical Officer, effective June 30, 2026. Low price impact (>=1%) expected as it is a significant executive transition, scheduled
6/30/2026, 12:00:00 AM
Honeywell International Inc (HON) · Trading Issue
Honeywell Aerospace spin-off is scheduled to be completed on June 29, 2026, marking the final step in the company's portfolio transformation. The new company will trade under the ticker 'HONA'. This event is scheduled.
6/29/2026, 12:00:00 AM
CrowdStrike Holdings Inc (CRWD) · Earnings Release
First quarter fiscal year 2027 earnings release on 2026-06-09 scheduled, with analyst EPS and revenue estimates forecasted. Importance is Medium as earnings releases are significant catalysts with ≥5% expected impact.
6/9/2026, 12:00:00 AM
Datadog Inc (DDOG) · Other
Datadog's annual conference, DASH, is scheduled to take place in New York City on June 9-10, 2026. Low impact is estimated as conference announcements typically have minimal market effect, scheduled.
6/9/2026, 12:00:00 AM